392 related articles for article (PubMed ID: 17950578)
1. DM1 CTG expansions affect insulin receptor isoforms expression in various tissues of transgenic mice.
Guiraud-Dogan C; Huguet A; Gomes-Pereira M; Brisson E; Bassez G; Junien C; Gourdon G
Biochim Biophys Acta; 2007 Dec; 1772(11-12):1183-91. PubMed ID: 17950578
[TBL] [Abstract][Full Text] [Related]
2. Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus.
Huguet A; Medja F; Nicole A; Vignaud A; Guiraud-Dogan C; Ferry A; Decostre V; Hogrel JY; Metzger F; Hoeflich A; Baraibar M; Gomes-Pereira M; Puymirat J; Bassez G; Furling D; Munnich A; Gourdon G
PLoS Genet; 2012; 8(11):e1003043. PubMed ID: 23209425
[TBL] [Abstract][Full Text] [Related]
3. Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities.
Seznec H; Agbulut O; Sergeant N; Savouret C; Ghestem A; Tabti N; Willer JC; Ourth L; Duros C; Brisson E; Fouquet C; Butler-Browne G; Delacourte A; Junien C; Gourdon G
Hum Mol Genet; 2001 Nov; 10(23):2717-26. PubMed ID: 11726559
[TBL] [Abstract][Full Text] [Related]
4. Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development.
Michel L; Huguet-Lachon A; Gourdon G
PLoS One; 2015; 10(9):e0137620. PubMed ID: 26339785
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features.
Dansithong W; Wolf CM; Sarkar P; Paul S; Chiang A; Holt I; Morris GE; Branco D; Sherwood MC; Comai L; Berul CI; Reddy S
PLoS One; 2008; 3(12):e3968. PubMed ID: 19092997
[TBL] [Abstract][Full Text] [Related]
6. The CTG repeat expansion size correlates with the splicing defects observed in muscles from myotonic dystrophy type 1 patients.
Botta A; Rinaldi F; Catalli C; Vergani L; Bonifazi E; Romeo V; Loro E; Viola A; Angelini C; Novelli G
J Med Genet; 2008 Oct; 45(10):639-46. PubMed ID: 18611984
[TBL] [Abstract][Full Text] [Related]
7. Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.
Wojtkowiak-Szlachcic A; Taylor K; Stepniak-Konieczna E; Sznajder LJ; Mykowska A; Sroka J; Thornton CA; Sobczak K
Nucleic Acids Res; 2015 Mar; 43(6):3318-31. PubMed ID: 25753670
[TBL] [Abstract][Full Text] [Related]
8. Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy.
Furling D; Lam le T; Agbulut O; Butler-Browne GS; Morris GE
Am J Pathol; 2003 Mar; 162(3):1001-9. PubMed ID: 12598332
[TBL] [Abstract][Full Text] [Related]
9. Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts.
Langlois MA; Lee NS; Rossi JJ; Puymirat J
Mol Ther; 2003 May; 7(5 Pt 1):670-80. PubMed ID: 12718910
[TBL] [Abstract][Full Text] [Related]
10. Staufen1 Regulates Multiple Alternative Splicing Events either Positively or Negatively in DM1 Indicating Its Role as a Disease Modifier.
Bondy-Chorney E; Crawford Parks TE; Ravel-Chapuis A; Klinck R; Rocheleau L; Pelchat M; Chabot B; Jasmin BJ; Côté J
PLoS Genet; 2016 Jan; 12(1):e1005827. PubMed ID: 26824521
[TBL] [Abstract][Full Text] [Related]
11. Expanded CTG repeat demarcates a boundary for abnormal CpG methylation in myotonic dystrophy patient tissues.
López Castel A; Nakamori M; Tomé S; Chitayat D; Gourdon G; Thornton CA; Pearson CE
Hum Mol Genet; 2011 Jan; 20(1):1-15. PubMed ID: 21044947
[TBL] [Abstract][Full Text] [Related]
12. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.
Savkur RS; Philips AV; Cooper TA
Nat Genet; 2001 Sep; 29(1):40-7. PubMed ID: 11528389
[TBL] [Abstract][Full Text] [Related]
13. DDX6 regulates sequestered nuclear CUG-expanded DMPK-mRNA in dystrophia myotonica type 1.
Pettersson OJ; Aagaard L; Andrejeva D; Thomsen R; Jensen TG; Damgaard CK
Nucleic Acids Res; 2014 Jun; 42(11):7186-200. PubMed ID: 24792155
[TBL] [Abstract][Full Text] [Related]
14. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat.
Mankodi A; Logigian E; Callahan L; McClain C; White R; Henderson D; Krym M; Thornton CA
Science; 2000 Sep; 289(5485):1769-73. PubMed ID: 10976074
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1.
Hino S; Kondo S; Sekiya H; Saito A; Kanemoto S; Murakami T; Chihara K; Aoki Y; Nakamori M; Takahashi MP; Imaizumi K
Hum Mol Genet; 2007 Dec; 16(23):2834-43. PubMed ID: 17728322
[TBL] [Abstract][Full Text] [Related]
16. Muscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brain.
Suenaga K; Lee KY; Nakamori M; Tatsumi Y; Takahashi MP; Fujimura H; Jinnai K; Yoshikawa H; Du H; Ares M; Swanson MS; Kimura T
PLoS One; 2012; 7(3):e33218. PubMed ID: 22427994
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of myogenesis in transgenic mice expressing the human DMPK 3'-UTR.
Storbeck CJ; Drmanic S; Daniel K; Waring JD; Jirik FR; Parry DJ; Ahmed N; Sabourin LA; Ikeda JE; Korneluk RG
Hum Mol Genet; 2004 Mar; 13(6):589-600. PubMed ID: 14734627
[TBL] [Abstract][Full Text] [Related]
18. Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.
Ranum LP; Day JW
Curr Neurol Neurosci Rep; 2002 Sep; 2(5):465-70. PubMed ID: 12169228
[TBL] [Abstract][Full Text] [Related]
19. Progressive skeletal muscle weakness in transgenic mice expressing CTG expansions is associated with the activation of the ubiquitin-proteasome pathway.
Vignaud A; Ferry A; Huguet A; Baraibar M; Trollet C; Hyzewicz J; Butler-Browne G; Puymirat J; Gourdon G; Furling D
Neuromuscul Disord; 2010 May; 20(5):319-25. PubMed ID: 20346670
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of expanded (CTG)•(CAG) repeats by antisense oligonucleotides.
Nakamori M; Gourdon G; Thornton CA
Mol Ther; 2011 Dec; 19(12):2222-7. PubMed ID: 21971425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]